Michigan State University
New way of viewing cells could lead to easier routes for drug manufacture
Published in Hepatitis Weekly, January 5th, 2009
Proteins used in drug manufacture and research often are made within genetically modified Escherichia coli, a one-cell bacteria. That protein tends to collect into what scientists call inclusion bodies. Those hard-to-separate clumps render up to 95 percent of the protein unusable, according to associate chemistry professor David P. Weliky.
Some can be recovered by breaking down the protein to separate it, but because protein...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2009-01-05)
More Articles from Hepatitis Weekly
- NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Hepatitis C treatment reduces the virus but liver damage continues - Saint Louis University
Using math to understand hep. C: Patterns paint picture of who will respond to treatment - B-Cell Lymphoma
New findings reported from Ehime Prefectural Central Hospital describe advances in B-cell lymphoma - Hepatitis B Virus
Investigators at Mersin University zero in on hepatitis B virus - Hepatitis B Virus
Reports outline hepatitis B virus research from B. Muneer and colleagues - Hepatitis B Virus
Research from G.Y. Gwak et al broadens understanding of hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
